General Biologicals (4117.TWO) Stock Price
General Biologicals Price
Over the last 19 years General Biologicals grew revenue by 1.0% annually, reaching 215.74 M TWD. Earnings per share have grown at 27.3% per year over the last 15 years. For General Biologicals, the net margin of 215.9% is up versus 8.0% a few years ago.
General Biologicals stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
General Biologicals business model & stock analysis
Frequently asked questions about General Biologicals
Converted at the current exchange rate, the General Biologicals share trades at 0.20 EUR (7.20 TWD).
The revenue cannot currently be calculated for General Biologicals.
The profit cannot currently be calculated for General Biologicals.
The P/E ratio cannot be calculated for General Biologicals at the moment.
The P/S cannot be calculated for General Biologicals currently.
The Eulerpool Quality Score for General Biologicals is 1/10.
The ISIN of General Biologicals is TW0004117007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of General Biologicals is 4117.TWO. The ticker symbol is used to trade General Biologicals shares on the stock exchange.
General Biologicals stock
General Biologicals Peer Group
General Biologicals FIGI
All fundamentals and in-depth analysis of General Biologicals
Our stock analysis for General Biologicals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of General Biologicals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.